Back to search

Poland· PL-100482400

Ganciclovir Delfarma

A medicinal product containing ganciclovirum, registered in Poland by Delfarma Sp. z o.o..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGanciclovir DelfarmaATC—REGISTER NO.PL-100482400PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Ganciclovirum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991513221
  • gtin
    05909991513238
  • gtin
    05909991513245
  • gtin
    05909991513252

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ganciclovirum in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganciclovirum products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Cymevene, Ganciclovir Oresund Pharma
  • Belgium · Cymevene, Virgan
  • Bulgaria · Ганцикловир Ромфарм
  • Czechia · Cymevene, Virgan
  • Germany · Cymeven I.V., Ganciclovir Accord
  • Denmark · Cymevene, Ganciclovir Oresund Pharma
  • Spain · Cymevene, Ganciclovir Accord
  • Finland · Cymevene, Ganciclovir Bioglan
  • France · Cymevan, Ganciclovir Hikma
  • United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
  • Greece · Gancilen, Virgan
  • Croatia · Cymevene
  • Hungary · Cymevene, Ganciclovir Rompharm
  • Ireland · Cymevene
  • Italy · Citovirax, Ganciclovir Accord
  • Luxembourg · Cymevene, Virgan
  • Netherlands · Cymevene, Ganciclovir Sandoz
  • Norway · Cymevene, Ganciclovir Bioglan
  • Portugal · Cymevene, Ganciclovir Accord
  • Romania · Ganciclovir Rompharm, Virgan
  • Sweden · Cymevene, Ganciclovir Bioglan
  • Slovakia · Cymevene

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7744cfa5-e54b-4943-8503-34f4ab213b1a
GET /v1/drugs/7744cfa5-e54b-4943-8503-34f4ab213b1a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania koncentratu roztworu do infuzji",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05909991513221 ¦ Lz ¦ 149922\n1 fiol. 500 mg proszku\n05909991513238 ¦ Lz ¦ 149923\n5 fiol. 500 mg proszku\n05909991513245 ¦ Lz ¦ 149924\n10 fiol. 500 mg proszku\n05909991513252 ¦ Lz ¦ 149925\n25 fiol. 500 mg proszku",
  "substance": "Ganciclovirum natricum 543 mg",
  "common_name": "Ganciclovirum",
  "pl_product_id": "100482400",
  "pozwolenie_nr": "27809",
  "auth_procedure": "NAR",
  "authorisation_validity": "2028-04-26"
}

See everything about ganciclovirum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.